BioAge Labs Inc.
BIOA | NASDAQ
$8.46
+$0.37 (+4.57%)
Sep 22, 2026, 2:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Net Income | -80.61M | -71.11M | -63.85M | -39.72M |
Depreciation & Amortization | 213K | 167K | 162K | 129K |
Stock-Based Compensation | 11.69M | 6.98M | 3.02M | 2.54M |
Other Working Capital | -11.85M | 11.17M | 7.1M | -199K |
Other Non-Cash Items | -1.1M | 1.27M | 16.6M | 77K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -11.83M | 11.18M | 6.71M | 795K |
Operating Cash Flow | -81.63M | -51.52M | -37.36M | -36.18M |
Capital Expenditures | -719K | -366K | -166K | -103K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -154.75M | n/a | -100K | n/a |
Sales Maturities Of Investments | 60.25M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | -95.22M | -366K | -266K | -103K |
Debt Repayment | -6M | -6M | 35M | 2.5M |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -400K | -4.42M | -59K | -45K |
Financial Cash Flow | 11.47M | 381.2M | 34.94M | 2.5M |
Net Cash Flow | -165.46M | 329.39M | -2.69M | -33.54M |
Free Cash Flow | -82.35M | -51.89M | -37.53M | -36.28M |
Adj. Free Cash Flow | -94.04M | -58.87M | -40.54M | -38.82M |
Maintenance CapEx | n/a | -167K | -162K | -103K |
Growth CapEx | -719K | -199K | -4K | n/a |
Owner Earnings | -81.63M | -51.69M | -37.52M | -36.28M |
Add to Watchlist
Select watchlists to add or remove BIOA